Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Access to radical and palliative radiotherapy in low- and middle-income countries: challenges, progress, and future
Maria Thereza Mansur Starling1, Omar Abdihamid2,3, Verna Vanderpuye4
1Department of Radiation Oncology, Hospital Madre Teresa, Belo Horizonte, Brazil.
Purpose Of Review:
Low- and middle-income countries (LMICs) bear over half of the global cancer mortality but have access to only 5% of global radiotherapy resources. As the cancer burden rises and equity in palliative care gains global attention, a focused review on palliative radiotherapy access in LMICs is both timely and necessary.
Recent Findings:
Barriers to radiotherapy access in LMICs are multifaceted, including infrastructure gaps, workforce shortages, geographic centralization, high out-of-pocket costs, and systemic underinvestment. Palliative radiotherapy, despite its proven cost-effectiveness and impact on quality of life, is often excluded from national cancer plans and health strategies. Innovative approaches such as hypofractionation, mobile units, AI-assisted planning, and public-private partnerships are emerging to address these gaps. Efforts by the International Atomic Energy Agency and local governments have led to progress in several regions, with case studies from Africa, Asia, and Latin America showing promising results.
Summary:
Integrating radiotherapy - particularly palliative radiotherapy - into national cancer and palliative care strategies is essential. Sustainable financing, decentralized service models, and context-specific technologies are critical to overcoming current limitations. Bridging this gap is not only a public health necessity but also a moral imperative to reduce suffering and support patients' dignity and societal contributions.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radiation: Applications
The average...

